Category: Cancer
Prostate Cancer Vaccine Meets Goal
Thursday, 16 April, 2009 05:38 Written by admin
Provenge, an experimental treatment vaccine for advanced prostate cancer, met researchers’ goal in a key trial needed for FDA approval.
That news comes from Dendreon, the company that makes Provenge.
“We believe this is truly a breakthrough for the prostate cancer community and a testament to the promise of the field of cancer immunotherapies,” Dendreon’s president and chief executive officer Mitchell Gold, MD, said in a conference call today.
Colorectal cancer most common
Friday, 13 March, 2009 20:36 Written by admin
Taiwan recorded 73,293 new cancer cases in 2006, with the largest number being colorectal cases, according to the latest cancer incidence report released yesterday by the Department of Health=.
The figures mean that on average, a new cancer patient was being diagnosed in the country every 7 minutes, 10 seconds in 2006, up slightly from the average of 7 minutes, 38 seconds in 2005, when 68,907 new cases were recorded, according to Chao Kun-yu, deputy chief of the DOH’s Bureau of Health Promotion.
The report showed that for the first time, colorectal cancer replaced liver cancer as the most common type among new cases recorded in a single year.
Nano-treatment to torpedo cancer
Friday, 13 March, 2009 20:15 Written by admin
Nanotechnology has been used for the first time to destroy cancer cells with a highly targeted package of “tumour busting” genes.
The technique, which leaves healthy cells unaffected, could potentially offer hope to people with hard-to-treat cancers where surgery is not possible.
Although it has only been tested in mice so far, the researchers hope for human trials in two years.
The UK study is published online by the journal Cancer Research.
Million Woman Study Links Alcohol Use to Cancer in Women
Saturday, 28 February, 2009 05:51 Written by admin
In seeming contradiction to previous studies where findings supported the benign or beneficial effects of alcohol consumption, a current study by researchers at the University of Oxford in Great Britain has linked even minimal alcohol use and cancer in women. The type of alcohol consumed was irrelevant.
The so-called Million Women Study of middle-aged women in the United Kingdom found that low to moderate consumption of alcohol increased the risk of and might be responsible for 13 percent of breast, liver, rectal and certain digestive tract cancers.
ASA404 to be developed in breast cancer
Thursday, 12 February, 2009 07:22 Written by admin
London, UK, and Cambridge, MA, 12 February 2009 – Antisoma plc (LSE: ASM; USOTC:ATSMY) announces that its Tumour-Vascular Disrupting Agent, ASA404, will be evaluated by Novartis as a treatment for HER2-negative metastatic breast cancer. This indication is being prioritised ahead of prostate cancer, in which a phase II trial has been completed. Details of the plans for trials in breast cancer will be available later this year.